|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Investments: | |||||||||||||||||||
| Fixed maturities, available for sale, at fair value (amortized cost: $1,365,368 and $1,337,235, allowance for expected credit losses of $355 and $0) | |||||||||||||||||||
| Short-term investments, at fair value (cost: $0 and $19,970) | |||||||||||||||||||
| Equity securities, at fair value (cost: $189,372 and $201,591) | |||||||||||||||||||
| Other invested assets | |||||||||||||||||||
| Total investments | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Accounts receivable, net of allowance for expected credit losses of $890 and $802 | |||||||||||||||||||
| Receivable for securities sold | |||||||||||||||||||
| Accrued investment income | |||||||||||||||||||
| Taxes recoverable | |||||||||||||||||||
| Receivable from reinsurers related to paid loss and loss adjustment expenses | |||||||||||||||||||
| Receivable from reinsurers related to unpaid loss and loss adjustment expenses | |||||||||||||||||||
| Ceded unearned premiums | |||||||||||||||||||
| Deferred policy acquisition costs | |||||||||||||||||||
| Deferred income taxes | |||||||||||||||||||
| Equity and deposits in pools | |||||||||||||||||||
| Operating lease right-of-use-assets | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Intangible assets | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities | |||||||||||||||||||
| Losses and loss adjustment expense reserves | |||||||||||||||||||
| Unearned premium reserves | |||||||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||||||
| Payable for securities purchased | |||||||||||||||||||
| Payable to reinsurers | |||||||||||||||||||
| Taxes payable | |||||||||||||||||||
| Short-term debt | |||||||||||||||||||
| Long-term debt | |||||||||||||||||||
| Debt | |||||||||||||||||||
| Operating lease liabilities | |||||||||||||||||||
| Other liabilities | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Shareholders' equity | |||||||||||||||||||
| Common stock: $0.01 par value; 30,000,000 shares authorized; 18,103,084 and 18,051,631 shares issued | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Accumulated other comprehensive loss, net of taxes | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Treasury stock, at cost: 3,419,947 shares | |||||||||||||||||||
| Total shareholders' equity | |||||||||||||||||||
| Total liabilities and shareholders' equity | |||||||||||||||||||
Loading...
